|1.||Findling, Robert L: 5 articles (05/2012 - 08/2007)|
|2.||McClellan, Jon: 4 articles (05/2012 - 08/2007)|
|3.||Lieberman, Jeffrey A: 4 articles (05/2012 - 08/2007)|
|4.||Sikich, Linmarie: 4 articles (05/2012 - 08/2007)|
|5.||Frazier, Jean A: 4 articles (05/2012 - 08/2007)|
|6.||Hamer, Robert M: 4 articles (05/2012 - 08/2007)|
|7.||Vitiello, Benedetto: 4 articles (05/2012 - 08/2007)|
|8.||Maloney, Ann E: 3 articles (06/2010 - 08/2007)|
|9.||Ritz, Louise: 3 articles (06/2010 - 08/2007)|
|10.||Johnson, Jacqueline L: 2 articles (05/2012 - 06/2010)|
|1.||Schizophrenia (Dementia Praecox)
09/01/2004 - "The antipsychotic (or neuroleptic) activity of molindone makes it particularly useful in the treatment of schizophrenia. "
06/01/2008 - "Efficacy of molindone in treatment-refractory agitated schizophrenia: three case reports."
01/01/2007 - "Molindone for schizophrenia and severe mental illness."
01/01/2000 - "Molindone for schizophrenia and severe mental illness."
12/01/1990 - "I report a patient who developed the syndrome during treatment for schizophrenia with the antipsychotic agent molindone hydrochloride. "
|2.||Psychotic Disorders (Schizoaffective Disorder)
01/01/2007 - "We included all randomised controlled trials that compared molindone to other treatments for schizophrenia and schizophrenia-like psychoses. "
01/01/2000 - "All randomised controlled trials that compared molindone to other treatments for schizophrenia and schizophrenia-like psychoses were included by independent assessment. "
01/01/2007 - "To determine the effects of molindone compared with placebo, typical and other atypical antipsychotic drugs for schizophrenia and related psychoses. "
01/01/2000 - "To determine the effects of molindone compared with placebo, typical and other atypical antipsychotic drugs for schizophrenia and related psychoses. "
11/01/2008 - "Risperidone and olanzapine did not demonstrate superior efficacy over molindone for treating early-onset schizophrenia and schizoaffective disorder. "
|3.||Neuroleptic Malignant Syndrome
10/01/1991 - "Neuroleptic malignant syndrome possibly caused by molindone hydrochloride."
09/01/1989 - "Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome."
09/01/1989 - "A case is reported in which neuroleptic treatment was successfully reintroduced with molindone after previous bouts of neuroleptic malignant syndrome (NMS) with trifluoperazine and thioridazine. "
01/01/1989 - "In this case, a patient with a history of probable neuroleptic malignant syndrome caused by administration, as single agents, of haloperidol, molindone, and lithium was later treated successfully with the novel antipsychotic clozapine. "
|4.||Movement Disorders (Movement Disorder)
01/01/1990 - "Tardive dyskinesia associated with molindone treatment."
07/01/1983 - "Tardive dyskinesia with molindone."
01/01/1982 - "These results with molindone in an animal model of tardive dyskinesia suggest that this drug may have a lower potential for eliciting this disorder in humans."
09/01/1977 - "Tardive dyskinesia oral facial dyskinesia with moban."
01/01/2007 - "Molindone is no more or less likely than typical drugs to cause movement disorders, but it does cause significantly more weight loss (2RCTs n=60 RR 2.78, CI 1.10 to 6.99, NNH 5 CI 2 to 77). "
02/01/1988 - "The selective D-1 blocker, molindone, also caused catalepsy at 5 and 10 mg/kg; and blockade of both receptor types produced additive cataleptogenic effects. "
12/01/1985 - "If D1 receptor blockade is necessary for catalepsy, molindone should not cause catalepsy. "
12/01/1985 - "To test this issue in a mouse model of catalepsy, these experiments tested molindone, a D2-blocking neuroleptic with almost no ability to block D1 receptors. "
06/01/1981 - "Effect of drugs influencing central 5-hydroxytryptaminergic mechanisms on molindone-induced catalepsy in the rat."
02/01/1988 - "The catalepsy of D-2 blockade with molindone was not potentiated by the D-1 agonist, SKF 38393, which slightly disrupted the catalepsy of D-2 blockade. "
|1.||Risperidone (Risperdal Consta)
|6.||Antipsychotic Agents (Antipsychotics)
|8.||Dopamine Receptors (Dopamine Receptor)